WHWK (Whitehawk Therapeutics) Quality Rank


WHWK Whitehawk Therapeutics Inc WHWK
38 GF Score
Price $3.98
GF Value $0.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Whitehawk Therapeutics Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Whitehawk Therapeutics Quality Rank Related Terms

WHWK
38GF Score
Whitehawk Therapeutics Inc WHWK
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Whitehawk Therapeutics (WHWK) Overvalued in 2026?

Based on GuruFocus' analysis, Whitehawk Therapeutics stock appears to be overvalued. The current stock price of $3.98 is trading 1374.1% above its estimated GF Value™ of $0.27. GuruFocus considers Whitehawk Therapeutics to be Significantly Overvalued.

Key valuation signals for WHWK:

  • Quality Rank:
  • GF Value™: $0.27 vs. price of $3.98 (1374.1% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the WHWK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Whitehawk Therapeutics Business Description

Other Exchanges 3350:Germany
Address 2 Headquarters Plaza East Building, 11th Floor, Morristown, New Jersey, NJ, USA, 07960
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
38GF Score

Get the complete analysis for WHWK

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.98
Price
$0.27
GF Value